Medical Exercise annual ebitda
2025
2026
Medical Exercise EBITDA Growth & History (MDXR)
Medical Exercise's calculated EBITDA was −$213,627 for fiscal 2026.
View full Medical Exercise company overviewMedical Exercise annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$213,627 | $106,255 | — |
| 2025 | 2025-03-31 | −$319,882 | — | — |
Medical Exercise quarterly ebitda
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | −$52,227 | $15,183 | — |
| Q4 2026 | 2026-03-31 | −$40,661 | $24,101 | — |
| Q3 2026 | 2025-12-31 | −$23,882 | $114,475 | — |
| Q2 2026 | 2025-09-30 | −$81,674 | −$22,695 | — |
| Q1 2026 | 2025-06-30 | −$67,410 | −$9,626 | — |
| Q4 2025 | 2025-03-31 | −$64,762 | — | — |
| Q3 2025 | 2024-12-31 | −$138,357 | — | — |
| Q2 2025 | 2024-09-30 | −$58,979 | — | — |
| Q1 2025 | 2024-06-30 | −$57,784 | — | — |
Medical Exercise ebitda trends
Between the periods ended 2025-03-31 and 2026-03-31, Medical Exercise's ebitda increased from −$319,882 to −$213,627, a change of $106,255. The latest reported quarter, Q1 2027, shows −$52,227.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medical Exercise source filings ↗